|
Market Cap (4-Jul) $3,153,122 (199th) |
Close (30-Jun) $0.091 |
Volume (30-Jun) 50,159,971 |
Shortsold (19-Jun) 392,315,164 (5.25%) (41st) |
|
52w High $2.75 |
52w Low $0.340 |
P/E - |
EPS -0.6 |
IMU released this announcement to the ASX on 30 August 2021, 12:16. The announcement is marked as price sensitive, and is 86 page(s) in length and 1.95MB in size.
You can view all announcements from IMU and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMU was 2.127% short sold according to ASIC data. It was ranked the 88th most shorted stock on the ASX. It is now ranked as the 41st most shorted stock on the ASX with 5.254% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMU | |
|---|---|
| Change of Director's Interest Notice | 30 June 2023, 16:33 |
| HER-Vaxx induced antibodies correlated with tumour reduction | 30 June 2023, 8:40 |
| Imugene PD1-Vaxx patent extended to 2040 | 29 June 2023, 8:39 |
| Appendix 4E and Full Year Statutory Accounts | 30 August 2021, 12:16 |
| Application for quotation of securities - IMU | 27 August 2021, 11:07 |
| Phase 1 Clinical Trial Update of Immunotherapy PD1-Vaxx | 27 August 2021, 8:11 |
| Response to ASX Query | 23 August 2021, 14:12 |
You must be logged in to post a reply.
Imugene 